Understanding institutional stakeholders' perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study

Journal article


Publication Details

Author(s): Heckel M, Herbst FA, Adelhardt T, Tiedtke J, Sturm A, Stiel S, Ostgathe C
Journal: Clinical Interventions in Aging
Publication year: 2017
Volume: 12
Pages range: 1605-1613
ISSN: 1176-9092
eISSN: 1178-1998


Abstract

Information lacks about institutional stakeholders' perspectives on management approaches of multidrug-resistant bacterial organism in end-of-life situations. The term "institutional stakeholder" includes persons in leading positions with responsibility in hospitals' multidrug-resistant bacterial organism management. They have great influence on how strategies on multidrug-resistant bacterial organism management approaches in institutions of the public health system are designed. This study targeted institutional stakeholders' individual perspectives on multidrug-resistant bacterial organism colonization or infection and isolation measures at the end of life.Between March and December 2014, institutional stakeholders of two study centers, a German palliative care unit and a geriatric ward, were queried in semistructured interviews. Interviews were audiotaped, transcribed verbatim, and analyzed qualitatively with the aid of the software MAXQDA for qualitative data analysis using principles of Grounded Theory. In addition, two external stakeholders were interviewed to enrich data.Key issues addressed by institutional stakeholders (N=18) were the relevance of multidrug-resistant bacterial organism in palliative and geriatric care, contradictions between hygiene principles and patients' and family caregivers' needs and divergence from standards, frame conditions, and reflections on standardization of multidrug-resistant bacterial organism end-of-life care procedures. Results show that institutional stakeholders face a dilemma between their responsibility in protecting third persons and ensuring patients' quality of life. Until further empirical evidence establishes a clear multidrug-resistant bacterial organism management approach in end-of-life care, stakeholders suggest a case-based approach.The institutional stakeholders' perspectives and their suggestion of a case-based approach advance the development process of a patient-, family-, staff-, and institutional-centered approach of how to deal with multidrug-resistant bacterial organism-positive patients in end-of-life care. Institutional stakeholders play an important role in the implementation of recommendations following this approach.


FAU Authors / FAU Editors

Adelhardt, Thomas Dr.
Lehrstuhl für Betriebswirtschaftslehre, insbesondere Gesundheitsmanagement
Heckel, Maria Dr. phil.
Abteilung für Palliativmedizin
Ostgathe, Christoph Prof. Dr.
Abteilung für Palliativmedizin
Sturm, Alexander
Professur für Innere Medizin - Geriatrie
Tiedtke, Johanna
Institut für Psychogerontologie


External institutions with authors

Medizinische Hochschule Hannover (MHH) / Hannover Medical School


How to cite

APA:
Heckel, M., Herbst, F.A., Adelhardt, T., Tiedtke, J., Sturm, A., Stiel, S., & Ostgathe, C. (2017). Understanding institutional stakeholders' perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study. Clinical Interventions in Aging, 12, 1605-1613. https://dx.doi.org/10.2147/CIA.S138429

MLA:
Heckel, Maria, et al. "Understanding institutional stakeholders' perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study." Clinical Interventions in Aging 12 (2017): 1605-1613.

BibTeX: 

Last updated on 2019-15-03 at 08:53